Business Standard

Russian coronavirus vaccine: Indian Embassy in touch with Sputnik developer

The Indian Embassy is awaiting the safety and efficacy data of the Russian coronavirus vaccine," according to reports

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

BS Web Team New Delhi
The third stage of the research on the world's first registered vaccine against the novel coronavirus, called Sputnik V, may begin in 7-10 days, a report has said.

According to the Tass news agency, several tens of thousands of people are expected to take part in this research of the vaccine created by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Russian Health Ministry.

Meanwhile, the Indian embassy in Moscow is in touch with the medical research institute, The Indian Express reported, quoting top officials.

“The Indian Mission is engaging separately with the Russian side through

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in